Article
iPSC culture expansion selects against putatively actionable mutations in the…
medRxiv · 2020 · Kosanke, M.; Davenport, C.; Szepes, M.; Wiehlmann, L.; Kohrn, T.; Dorda, M.; Gruber, J.; Menge, K.; Sievert, M.; Melchert, A.; Gruh, I.; Martin, U.
Key facts
| Title | iPSC culture expansion selects against putatively actionable mutations in the mitochondrial genome |
|---|---|
| First author | Kosanke, M.; Davenport, C.; Szepes, M.; Wiehlmann, L.; Kohrn, T.; Dorda, M.; Gruber, J.; Menge, K.; Sievert, M.; Melchert, A.; Gruh, I.; Martin, U. |
| Journal | medRxiv |
| Published | Nov 5, 2020 |
| DOI | 10.1101/2020.11.05.369694 |
| Devices mentioned | BK110039, DEN000008, K022086, K103302, K963139 |
| Product codes mentioned | DDD, DDG, JCI, JJH, KIP, KIT, NDS, NJT, OOI, PFF, PFT, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1